Solistaa Pharmaceuticals

Solistaa Pharmaceuticals is an Indian contract development and manufacturing organization (CDMO) specializing in nutraceuticals, dietary supplements, and pharmaceutical formulations. Established in 2017 and headquartered in Puducherry, the company operates a dedicated manufacturing facility in Tamil Nadu that produces various dosage forms, including multivitamin gummies, soft chews, tablets, capsules, and oral liquids. Solistaa provides a comprehensive suite of services, including formulation development, quality control, analytical testing, and regulatory filing support. In 2026, Amapharm became the largest shareholder of Solistaa, integrating the company into the Amapharm Group to accelerate its global growth and expand its reach in the dietary supplement and pharmaceutical sectors.